Osteosarcoma is the most common primary bone tumor in children and adolescents, typically presenting with a poor prognosis. Octamer-binding transcription factor 4 (Oct4) protein, encoded by the POU class 5 homeobox 1 gene, is important in maintaining self-renewal of pluripotent stem cells, and is closely associated with cancer. However, its role in osteosarcoma remains to be elucidated. The present study observed Oct4 was markedly increased in osteosarcoma cell lines and in human osteosarcoma tissue samples. Following Oct4 downregulation by small interfering RNA (siRNA) in osteosarcoma F5M2 cells, the cells exhibited significant decreases in proliferation and invasion ability, and an increase in cell apoptosis. Notably, downregulation of Oct4 decreased the expression of AK055347, a newly identified long noncoding RNA (1ncRNA) in human tissues. The downregulation of AK055347 by siRNA resulted in a significant suppressive effect on proliferative and invasive ability, and promotion of cell apoptosis in osteosarcoma cells. Thus, the current study suggests Oct4 exerts a promoting effect in osteosarcoma, and identifies a novel IncRNA in osteosarcoma progression.
[1]Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun 130001, Jilin, Peoples R China.
[2]Jilin Univ, China Japan Union Hosp, Dept Anesthesiol, Changchun 130001, Jilin, Peoples R China.
[3]Jilin Univ, Hosp 2, Orthoped Hosp, Dept Orthoped, 218 Ziqiang St, Changchun 130001, Jilin, Peoples R China.
(8.0+极速模式)